Skip to main content
Caplight Logo









Otomagnetics, Inc.

Otomagnetics, Inc.

Private
Gaithersburg, MarylandHealthcare & Life Scienceshttps://otomagnetics.com/

Last Round

Series A

Feb 1, 2020

Total Funding Raised

$5.24M

Company Overview

Otomagnetics, Inc. is a medical device company that develops a non-invasive magnetic drug delivery platform for targeted therapies in the ear, eye, and skin.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

drug delivery platformmagnetic drug deliverynon-invasive surgerymedical devicebiotechnologydrug delivery systemtargeted therapyotolaryngologyophthalmologybiodegradable particlesneedle-free injectionbiotech platformdrug formulationnanomedicinemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Otomagnetics, Inc. Comparables

Compare Otomagnetics, Inc. with similar companies based on industry and business-model similarity.

Otomagnetics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Opharmic Technology
78%
Spiral Therapeutics
78%
Starpax Biopharma Inc.
77%

Otomagnetics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 1, 2020
GrantOct 12, 2017
AngelJul 1, 2017
SeedDec 14, 2016

Otomagnetics, Inc. Investors

Notable investors and investment history

Otomagnetics, Inc. investors
InvestorRounds
National Cancer InstituteGrant
NIH RADxGrant
TEDCOSeed
Maryland Industrial Partnerships (MIPS)Grant
AngelMDAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2020

    $2.3M round led by Neela Chipalkatty

Otomagnetics, Inc. Filings

Explore SEC and related filing metadata, where available.

Otomagnetics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Otomagnetics, Inc.'s valuation, stock price, and market status.

Is Otomagnetics, Inc. a public or private company?

Otomagnetics, Inc. is a private company.

What is the current stock price of Otomagnetics, Inc.?

Otomagnetics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Otomagnetics, Inc. worth (valuation)?

Valuation information for Otomagnetics, Inc. is not publicly available.

Can I buy Otomagnetics, Inc. stock?

Otomagnetics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Otomagnetics, Inc.'s last funding round?

Otomagnetics, Inc.'s most recent funding round was Series A on February 1, 2020.

Who are the main investors in Otomagnetics, Inc.?

Key investors in Otomagnetics, Inc. include National Cancer Institute, NIH RADx, TEDCO, Maryland Industrial Partnerships (MIPS), AngelMD.

Will Otomagnetics, Inc. IPO soon?

No public IPO plans have been announced for Otomagnetics, Inc..

How can I track Otomagnetics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Otomagnetics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGaithersburg, Maryland
Employee Range5
Year Founded2012
Last FundingFeb 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?